FDA Adverse Event Death Summary report: N

EKOSONIC KIT 106CM 12CM TZ

MDR report key: 10079233 · Received May 21, 2020

Report

Report Number
2134265-2020-06839
Event Type
Death
Date Received
May 21, 2020
Date of Event
December 26, 2019
Report Date
May 21, 2020
Manufacturer
BTG BOTHELL
Product Code
KRA
PMA / PMN Number
K182324
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IN, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

STEWART, LAUREN, K., (2020) "EFFECT OF METABOLIC SYNDROME ON MEAN PULMONARY ARTERIAL PRESSURES IN PATIENTS WITH ACUTE PULMONARY EMBOLISM TREATED WITH CATHETER-DIRECTED THROMBOLYSIS" INTERNATIONAL JOURNAL OF CARDIOLOGY 302 PP.138-142.

Description of Event or Problem · 1

REPORTED VIA JOURNAL ARTICLE. IT WAS REPORTED THERE WERE 9 DEATHS ACROSS ALL PATIENTS. THE OBJECTIVE WAS TO MEASURE THE PREVALENCE OF METABOLIC SYNDROME (METS) IN PATIENTS WITH ACUTE PE RECEIVING CATHETER-DIRECTED THROMBOLYSIS (CDT) EKOS AND TO INVESTIGATE ITS EFFECT ON MEAN PULMONARY ARTERIAL PRESSURE AND OVERALL TREATMENT SUCCESS. THE PRESENCE OR ABSENCE OF METS COMPONENTS WERE EXTRACTED BASED ON THE FOLLOWING CRITERIA: BODY MASS INDEX (BMI) N30 KG/M2; DIAGNOSED HYPERTENSION: DIABETES MELLITUS (INCLUDING HBA1C N6.5) AND; 4. DYSLIPIDEMIA (INCLUDING TRIGLYCERIDES N150 MG/DL OR HIGH-DENSITY LIPOPROTEIN B40 MG/DL). THERE WERE 9 DEATHS ACROSS ALL PATIENTS (7%). THE MORTALITY RATE STRATIFIED BY NUMBER OF METS CRITERIA WAS AS FOLLOWS: 10% IN THOSE WITH 0 COMPONENTS, 3WITH 1 COMPONENT, 6WITH 2 COMPONENTS, 6% WITH 3 COMPONENTS AND 18% WITH ALL 4 COMPONENTS. CAUSE OF DEATHS ARE UNKNOWN AS DEVICE, PROCEDURE RELATIONSHIP WAS NOT PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
543771 EKOSONIC KIT 106CM 12CM TZ CATHETER, CONTINUOUS FLUSH KRA BTG BOTHELL

Patients

Seq Age Sex Outcome Treatment
1 Death